ScimeraMD® develops cutting-edge bioceuticals to…
1. Ensure maximal customer health and benefit,
2. Uphold the highest benchmark of quality,
3. To continually set the standard within the Bioceutical industry.
ScimeraMD is constantly researching and developing the newest and latest products that will support your health and wellness. We continually focus on promoting health through advanced bioscience.
The ScimeraMD team is composed of physicians, pharmacists, chemists, microbiologists, and consumer advocates to provide a comprehensive, quality-centric approach to product development. Through our extensive clinical exposure and expertise, ScimeraMD delivers the highest quality bioceuticals to support overall health and wellness. Our success is derived from our principles in evidenced based research, outcomes data, patient safety, and superior product standard of quality.
All of our products are made in the USA in an FDA-Inspected facility that meets the stringent standards of Good Manufacturing Practice (GMP) and US Pharmacopeia guidelines. To do this, we utilize the best clinical studies, advanced ingredient research, and evidence-based data, and we strive to promote better understanding and the importance of proactive intervention.
Our Founder and CEO
Frederick M. Chaleff, MD FACC
What seems to matter more than our beliefs is how we act upon them for the greater good of our customers. Our daily decisions as a company have the power to change lives and we never take that for granted- We welcome you to our family of products!
Dr. Frederick Chaleff MD, highly regarded Interventional Cardiologist who has been practicing in South Florida for over 25 years. He was voted to the List of TOP DOCTORS in South Florida and former Director of the Cardiac Cath Lab at Westside Regional Medical Center and is known for his strong belief that a proper diet, rich in essential nutrients and lifestyle modification are extremely important to optimize overall health and wellness.
Dr Chaleff received his Medical Degree from the University of Pittsburgh School of Medicine and conducted his Internal Medicine Internship, Residency, General Cardiology and Interventional Cardiology Fellowship at the University of Miami/Jackson Memorial Hospital/VA Medical Center Health Care system.
Dr Chaleff has been extensively involved in clinical research including Acute Coronary Syndrome (APPRAISE-2) Sub-Investigator, Post-MI -A randomized, double-blind placebo controlled event driven trial in the prevention of recurrent cardiovascular events in post-mi patients with elevated hsCRP Phase 3 Principal Investigator, Dyslipidemia in Acute Coronary Syndrome (ODYSSEY Outcomes 2015), Lipid Management Palm regisrty 2015 Sub-Investigator, Diabetes in Patients with Cardiovascular and microvascular risks (CARMELINA) and PCSK-9 Monoclonal AB Rx for Treatment of Dyslipidemia.
ScimeraMD is constantly researching and developing the newest and latest products that will support your health and wellness. We continually focus on promoting health through advanced bioscience.Shop Now
Reliability & Prestige
Our products are physician formulated based on the best and latest clinical studies and our facility is FDA inspected. Our company is dedicated, passionate, and committed to excellence in developing the next generation of Nutraceuticals.Our Blogs